All the more reason to worry that Covid vaccines may have tarnished ... Thrombosis caused by the AstraZeneca vaccine and ...
Pfizer beat first-quarter profit estimates on Wednesday, benefiting from cost cuts and strong sales for its pneumonia and ...
Cancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA vaccine for glioma offers ...
Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and ...
Since the February 26, 2024, announcement at ViVE of the development of the "Smart Hospital Maturity Model," enthusiasm from across the industry has led to broader involvement to guide the initiative.
Sales of Pfizer’s COVID products Comirnaty (vaccine) and Paxlovid (antiviral) decreased from $7.1 billion in the first ...
The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral ...
House prices fell for a second month in a row as mortgage lenders put up race, according to a lender. Property values dropped ...